Nuveen’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Nuveen’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-525,036	Closed	-$521K	–	3566
2022 Q1	$521K	Buy	525,036 +647	+0.1%	+$773	﹤0.01%	3002
2021 Q4	$1.18M	Buy	524,389 +276,479	+112%	+$694K	﹤0.01%	2800
2021 Q3	$900K	Sell	247,910 -5,882	-2%	-$18.1K	﹤0.01%	3025
2021 Q2	$759K	Buy	+253,792	New	+$803K	﹤0.01%	3093

Other funds holding INFI

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Nuveen's INFI Position: Q2 2022 in Review

Nuveen sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q2 2022, closing a stake of 525,036 shares — an estimated $521K sold.

Nuveen first reported a position in INFI in Q2 2021 and held it in 4 quarters. The position peaked at $1.18M in Q4 2021. 77 funds tracked by Wall St. Rank hold INFI as of Q2 2022.

Nuveen reported no remaining Infinity Pharmaceuticals, Inc. position as of Q2 2022 after selling out during the quarter.
Nuveen sold 525,036 Infinity Pharmaceuticals, Inc. shares in Q2 2022, an estimated $521K.
Nuveen first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2021 and held it in 4 quarters.
Nuveen's Infinity Pharmaceuticals, Inc. position peaked at $1.18M in Q4 2021.
77 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q2 2022.

Based on Nuveen's 13F filing for Q2 2022, filed 15 Aug 2022.